Literature DB >> 18961255

Spectrophotometric determination of platinum with o-phenylenediamine.

E D Golla1, G H Ayres.   

Abstract

Platinum(IV or II) reacts with o-phenylenediamine, at pH 6.5, to form light blue solutions having maximum absorption at 703 nm. The reaction, slow at room temperature, is complete in 3-4 min at temperatures near 100 degrees . Use of dimethylformamide in the solution prevents precipitation of the reaction product. The colour is stable for at least 24 hr. Effects of heating temperature and time, pH, reagent concentration, and other variables have been studied. The system conforms to Beer's law over the concentration range investigated. Optimum concentration range for measurement in 10-mm cells is 0.4-1.4 ppm of platinum; the molar absorptivity is 9.83 x 10(3) l. mole(-1). mm(-1). Interference from foreign ions has been evaluated, and methods for removal or masking of interferences have been tested. In the colour-forming reaction, platinum(IV) is reduced by the organic reagent to platinum(II), which is then complexed with the reagent. The metal : ligand ratio of 1 : 2 was indicated by solution spectrophotometric measurements, and was confirmed on the solid reaction product by elemental analysis and by mass spectrometric examination.

Entities:  

Year:  1973        PMID: 18961255     DOI: 10.1016/0039-9140(73)80267-x

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  12 in total

1.  Cervical cancer treatment with a locally insertable controlled release delivery system.

Authors:  Vandana Keskar; Prem S Mohanty; Ernest J Gemeinhart; Richard A Gemeinhart
Journal:  J Control Release       Date:  2006-08-26       Impact factor: 9.776

2.  Development of pH-sensitive pectinate/alginate microspheres for colon drug delivery.

Authors:  Fu-Yin Hsu; Ding-Syuan Yu; Chun-Chiang Huang
Journal:  J Mater Sci Mater Med       Date:  2012-10-27       Impact factor: 3.896

3.  Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels.

Authors:  Weiqi Zhang; Zhe Zhang; Ching-Hsuan Tung
Journal:  Chem Commun (Camb)       Date:  2017-01-05       Impact factor: 6.222

4.  Matrix metalloprotease selective peptide substrates cleavage within hydrogel matrices for cancer chemotherapy activation.

Authors:  Jovita R Tauro; Bao-Shiang Lee; Syed S Lateef; Richard A Gemeinhart
Journal:  Peptides       Date:  2008-07-05       Impact factor: 3.750

5.  Redox-responsive cisplatin nanogels for anticancer drug delivery.

Authors:  Weiqi Zhang; Ching-Hsuan Tung
Journal:  Chem Commun (Camb)       Date:  2018-07-24       Impact factor: 6.222

6.  Optimum removal conditions of aniline compounds in simulated wastewater by laccase from white-rot fungi.

Authors:  Bo Yang; Yacheng Wang; Zhiguo Liu; Jun Liu; Jiaming Cai
Journal:  J Environ Health Sci Eng       Date:  2019-01-15

7.  Fabrication and Cytotoxicity of Fucoidan-Cisplatin Nanoparticles for Macrophage and Tumor Cells.

Authors:  Pai-An Hwang; Xiao-Zhen Lin; Ko-Liang Kuo; Fu-Yin Hsu
Journal:  Materials (Basel)       Date:  2017-03-14       Impact factor: 3.623

8.  Hyaluronan-cisplatin conjugate nanoparticles embedded in Eudragit S100-coated pectin/alginate microbeads for colon drug delivery.

Authors:  Shiao-Wen Tsai; Ding-Syuan Yu; Shu-Wei Tsao; Fu-Yin Hsu
Journal:  Int J Nanomedicine       Date:  2013-07-03

9.  Evaluation of anti-metastatic potential of Cisplatin polymeric nanocarriers on B16F10 melanoma cells.

Authors:  Shruti S Shrikhande; Darshana S Jain; Rajani B Athawale; Amrita N Bajaj; Peeyush Goel; Zahid Kamran; Yuvraj Nikam; Rajiv Gude
Journal:  Saudi Pharm J       Date:  2015-01-06       Impact factor: 4.330

10.  Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer.

Authors:  Jing Huang; Weiping Qian; Liya Wang; Hui Wu; Hongyu Zhou; Andrew Yongqiang Wang; Hongbo Chen; Lily Yang; Hui Mao
Journal:  Int J Nanomedicine       Date:  2016-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.